Sickle cell disease: clinical management (Q33953641)

30 July 2017

1 reference

title

Sickle cell disease: clinical management (English)

1 reference

30 July 2017

0 references

Ballas SK

1

1 reference

30 July 2017

publication date

1 March 1998

1 reference

Best Practice and Research: Clinical Haematology

30 July 2017

published in

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

185-214

1 reference

The use of transcranial ultrasonography to predict stroke in sickle cell disease.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Alpha thalassemia and stroke risk in sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

The sickle cell painful crisis in adults: phases and objective signs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Erythrocytes in Hb SC disease are microcytic and hyperchromic

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Is Hb A2 elevated in adults with sickle-alpha-thalassemia (beta(S)/beta(S); -alpha/-alpha)?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

The prevalence of avascular necrosis in sickle cell anemia: correlation with alpha-thalassemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Clinical, hematological, and biochemical features of Hb SC disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Hyperkalemic hyperchloremic metabolic acidosis in sickle cell hemoglobinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Eye disease in sickling disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Sickle Cell Vaso-Occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Bone marrow transplantation for severe sickle cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

The treatment of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Treatment of sickle cell anemia with hydroxyurea and erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Hepatic sequestration in sickle cell anaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

The lung in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Pulmonary edema. Complication in the management of sickle cell pain crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Homocysteine in sickle cell disease: relationship to stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

"Blister cells". Association with pregnancy, sickle cell disease, and pulmonary infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Mitral valve prolapse in sickle cell disease. Presumptive evidence for a linked connective tissue disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Acute myocardial infarction in sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Sickle cell disease as a cause of osteonecrosis of the femoral head

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Serum Folate and Risk of Fatal Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Totally implantable intravenous catheters in the management of sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Pain in sickle cell disease. Rates and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Sickle cell anemia and major organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

1 reference

7 January 2021

The natural history of stroke in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Use of selective vasodilation in treatment of sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Is "relative" hypertension a risk factor for vaso-occlusive complications in sickle cell disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Rib infarcts and acute chest syndrome in sickle cell diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Transfusion therapy for cerebrovascular abnormalities in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

The painful crisis of homozygous sickle cell disease: clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Exchange transfusion for sickle cell intrahepatic cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

The unusual severity of Mycoplasmal pneumonia in children with sickle-cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Severe mycoplasma pneumonia with pleural effusions in a patient with sickle cell-hemoglobin C(SC) disease. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Core decompression in avascular necrosis of the hip in sickle-cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Modified method of exchange transfusion in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Causes of death in sickle-cell disease in Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Pulmonary complications

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Bone marrow transplantation for sickle cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

Hyporeninemic hypoaldosteronism in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2898%2980075-9

7 January 2021

10.1016/S0950-3536(98)80075-9

Identifiers

DOI

1 reference

30 July 2017

1 reference